Skip to main content
Ian Ganly, MD, Otolaryngology (ENT), New York, NY, Memorial Sloan Kettering Cancer Center

IanGanlyMDPhD, MS, FRCS, FRCS-ORL

Otolaryngology (ENT) New York, NY

Professor, Otolaryngology , Head & Neck Surgery, Weill Cornell Medical College, New York. Attending Surgeon, Head and Neck Service, Memorial Sloan Kettering Cancer Center, New York

Overview of Dr. Ganly

Dr. Ian Ganly is an otolaryngologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, NYC Health + Hospitals / Bellevue, and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from University of Glasgow Faculty of Medicine and has been in practice 28 years. Dr. Ganly accepts several types of health insurance, listed below. He is one of 22 doctors at Memorial Sloan Kettering Cancer Center and one of 45 doctors at NYC Health + Hospitals / Bellevue who specialize in Otolaryngology (ENT). He has more than 100 publications and over 500 citings.

Education & Training

  • University of Glasgow Faculty of Medicine
    University of Glasgow Faculty of MedicineClass of 1989

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2006 - 2024

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Multi-Dimensional Genomic Analysis of Myoepithelial Carcinoma Identifies Prevalent Oncogenic Gene Fusions  
    Ian Ganly, Alan L Ho, Ronald Ghossein, Nadeem Riaz, Cristina R Antonescu, Nora Katabi, Nature

Press Mentions

  • Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell Carcinoma
    Clinicopathologic Characteristics of Young Patients with Oral Squamous Cell CarcinomaApril 2nd, 2021
  • Pretreatment Neutrophil-to-Lymphocyte Ratio and Mutational Burden as Biomarkers of Tumor Response to Immune Checkpoint Inhibitors
    Pretreatment Neutrophil-to-Lymphocyte Ratio and Mutational Burden as Biomarkers of Tumor Response to Immune Checkpoint InhibitorsFebruary 1st, 2021
  • Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun Belt
    Metastatic Cutaneous Squamous Cell Carcinoma Involving the Parotid Gland: Experience Outside of the Sun BeltJanuary 8th, 2021
  • Join now to see all

Hospital Affiliations

Insurance Accepted

  • BCBS Blue Card PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Empire BCBS HMO
    Empire BCBS PPO
    GHI PPO
    Great West PPO
    Multiplan PHCS PPO
    Multiplan PPO
    MVP Healthcare PPO
    Oxford Health Freedom
    Oxford Health Liberty
    QualCare HMO
    QualCare PPO
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment